ArticleJournal of clinical medicine2022

Component-Resolved Evaluation of the Risk and Success of Immunotherapy in Bee Venom Allergic Patients.

Marta Rosiek-Biegus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.